Sevoflurane preconditioning can protect against cerebral ischemia by increasing the anti-inflammatory phenotype of microglia through activating the GSK-3β/NRF2 pathway (Cai et al., 2021). The gene discussed is NFE2L2; the disease is brain ischemia.